Pennsylvania jury awards William Melissen $78M for Roundup weedkiller link to his non-Hodgkin's lymphoma; Bayer plans to appeal. El jurado de Pensilvania otorga a William Melissen $ 78M por el vínculo del herbicida Roundup con su linfoma no Hodgkin; Bayer planea apelar.

A Pennsylvania jury awarded William Melissen $78 million, concluding that his use of Bayer's Roundup weedkiller contributed to his non-Hodgkin's lymphoma. Un jurado de Pensilvania otorgó a William Melissen $78 millones, concluyendo que su uso del herbicida Roundup de Bayer contribuyó a su linfoma no Hodgkin. The award includes $3 million in compensatory damages and $75 million in punitive damages. El premio incluye $3 millones en daños compensatorios y $75 millones en daños punitivos. Bayer asserts that glyphosate, the active ingredient, is safe and plans to appeal the decision. Bayer afirma que el glifosato, el ingrediente activo, es seguro y planea apelar la decisión. This case adds to the ongoing legal challenges faced by Bayer, with around 58,000 claims still pending. Este caso se suma a las actuales impugnaciones jurídicas a las que se enfrenta Bayer, con unas 58.000 reclamaciones pendientes.